Aleafia Health Beheer

Beheer criteriumcontroles 3/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Tricia Symmes

Algemeen directeur

CA$483.2k

Totale compensatie

Percentage CEO-salaris	58.7%
Dienstverband CEO	1.5yrs
Eigendom CEO	n/a
Management gemiddelde ambtstermijn	2.2yrs
Gemiddelde ambtstermijn bestuur	2.1yrs

Recente managementupdates

Recent updates

Analyse CEO-vergoeding

Hoe is Tricia Symmes's beloning veranderd ten opzichte van Aleafia Health's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Mar 31 2023	n/a	n/a	-CA$35m
Dec 31 2022	n/a	n/a	-CA$12m
Sep 30 2022	n/a	n/a	-CA$58m
Jun 30 2022	n/a	n/a	-CA$146m
Mar 31 2022	CA$483k	CA$284k	-CA$136m
Dec 31 2021	n/a	n/a	-CA$166m
Sep 30 2021	n/a	n/a	-CA$312m
Jun 30 2021	n/a	n/a	-CA$248m
Mar 31 2021	n/a	n/a	-CA$252m
Dec 31 2020	CA$496k	CA$107k	-CA$256m

Compensatie versus markt: De totale vergoeding ($USD 356.83K ) Tricia } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de German markt ($USD 476.59K ).

Compensatie versus inkomsten: De vergoeding van Tricia is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Tricia Symmes

1.5yrs

Tenure

CA$483,223

Compensatie

Ms. Patricia Symmes, also known as Tricia, serves as Chief Executive Officer of Aleafia Health Inc. since February 7, 2022 and served as its Chief Commercial Officer since August 27, 2020 until February 7,...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Patricia Symmes	Chief Executive Officer	1.5yrs	CA$483.22k	geen gegevens
Matthew Sale	Chief Financial Officer	2.2yrs	CA$238.91k	0.0025% € 136.0
Nicholas Bergamini	Vice-President of Investor Relations & Communications	no data	geen gegevens	geen gegevens
David Shepherd	Senior Vice President of Human Resources	4.6yrs	geen gegevens	0.00031% € 17.0

2.2yrs

Gemiddelde duur

Ervaren management: Het managementteam van ARAH wordt beschouwd als ervaren (gemiddelde ambtstermijn 2.2 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
David Pasieka	Independent Chairman	1.9yrs	CA$49.40k	0.0074% € 408.0
Luciano Galasso	Independent Director	1.9yrs	CA$103.39k	0.050% € 2.7k
Ian Troop	Independent Director	2.2yrs	CA$86.44k	0.0014% € 74.6
Jon Pereira	Independent Director	2.1yrs	CA$65.11k	1.42% € 77.9k
Carlo Sistilli	Independent Director	2.6yrs	CA$92.14k	0.011% € 598.3

2.1yrs

Gemiddelde duur

66yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van ARAH wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 2.1 jaar), wat duidt op een nieuw bestuur.

Aleafia Health Beheer

Beheer criteriumcontroles 3/4

Belangrijke informatie

Recente managementupdates

High number of new and inexperienced directors

Aleafia Health Inc. Announces Board Changes

High number of new and inexperienced directors

High number of new and inexperienced directors

Aleafia Health Inc., Annual General Meeting, Sep 27, 2022

High number of new and inexperienced directors

Recent updates

Red White & Bloom Brands Inc. (CNSX:RWB) completed the acquisition of One Plant (Retail) Corp. and Certain assets of Aleafia Health Inc. for $31.7 million.

Red White & Bloom Brands Inc. (CNSX:RWB) acquired Certain assets of Aleafia Health Inc. for $31.6677 million.

Red White & Bloom Brands Inc. (CNSX:RWB) entered into a stalking horse asset purchase agreement to acquire Certain assets of Aleafia Health Inc.

Aleafia Health Obtains Creditor Protection to Pursue Restructuring and Sale Process

New major risk - Financial position

Full year 2023 earnings released: CA$0.09 loss per share (vs CA$0.42 loss in FY 2022)

Red White & Bloom Brands Inc. (CNSX:RWB) entered into a binding letter agreement to acquire Aleafia Health Inc. (TSX:AH) from shareholders for CAD 74.98 million.

High number of new and inexperienced directors

Third quarter 2023 earnings released: CA$0.062 loss per share (vs CA$0.22 loss in 3Q 2022)

Aleafia Health Inc. to Report Q3, 2023 Results on Feb 08, 2023

Now 33% undervalued

Aleafia Health Inc. Announces Board Changes

Now 36% undervalued after recent price drop

High number of new and inexperienced directors

High number of new and inexperienced directors

Aleafia Health Inc. to Report Q2, 2023 Results on Nov 09, 2022

Aleafia Health Expands Sunday Market House of Brands with Coveted Lineup of Winter Product Launches

Aleafia Health Announces TSX Decision to Extend Delisting Review Period to November 29, 2022

Aleafia Health Inc. to Report Q2, 2022 Results on Aug 11, 2022

Aleafia Health Inc., Annual General Meeting, Sep 27, 2022

High number of new and inexperienced directors

Full year 2022 earnings released: CA$0.42 loss per share (vs CA$0.84 loss in FY 2021)

Aleafia Health Inc. Reaffirms Revenue Guidance for the Fiscal Year 2023

Aleafia Health Inc. announced that it has received CAD 5.6225 million in funding

High number of new and inexperienced directors

Aleafia Health Inc. announced that it expects to receive CAD 5.6225 million in funding

High number of new and inexperienced directors

Aleafia Health Inc. Reaffirms Earnings Guidance for the Fiscal Year 2022

Aleafia Health Inc. Announces Impairment of Property, Plant & Equipment for the Fourth Quarter Ended December 31, 2021

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Aleafia Health Inc. to Report Q4, 2021 Results on Feb 14, 2022

Aleafia Health Inc. Announces Executive Changes

Third quarter 2021 earnings released: CA$0.25 loss per share (vs CA$0.066 loss in 3Q 2020)

High number of new and inexperienced directors

Aleafia Health Launches Premium Cannabis Brand Nith & Grand

Aleafia Health Expands Bogart’s Kitchen Edibles Portfolio with Launch of Salted Caramel Pretzel Bites

Aleafia Health Inc. Announces It Has Largely Completed Planting Across 86 Acres At Its Outdoor Cultivation Facility in Port Perry, Ont

Aleafia Health Inc. Expands Trailblazing Wellness Brand Noon & Night with Launch of Freshly Minted Roll-On

CFO & Corporate Secretary Benjamin Ferdinand has left the company

Aleafia Health Inc.'s Everyday Cannabis Brand Divvy Launches Large Format Dried Flower Portfolio

First quarter 2021 earnings released: CA$0.036 loss per share (vs CA$0.022 loss in 1Q 2020)

Aleafia Health Inc. Secures Health Canada Research Licence

Full year 2020 earnings released: CA$0.85 loss per share (vs CA$0.18 loss in FY 2019)

Aleafia Health Expands Adult-Use Presence with Entrance in Saskatchewan, New Provincial Market

Aleafia Health Inc. has completed a Composite Units Offering in the amount of CAD 19.92 million.

Aleafia Health Inc. Launches THC Soft Chews Under its Edibles Brand Bogart’s Kitchen

Aleafia Health Inc. to Report Q4, 2020 Results on Mar 25, 2021

Aleafia Health Secures Licence for Toronto Distribution Centre, Expanding Supply Chain and Ecommerce Opportunity

Aleafia Health Inc. Launches Sunday Market House of Brands

New 90-day high: €0.59

Aleafia Health Inc. Announces Directorship Appointments

Aleafia Health Announces Resignation Rhonda Lawson as Director

Unifor and Aleafia Health Enter Exclusive Agreement to Support Medical Cannabis Coverage for Members

Aleafia Health Inc. Enters Definitive Supply Agreement with Apipharm

Unifor and Aleafia Health Inc. Partner on Groundbreaking Medical Cannabis Coverage

New 90-day high: €0.38

Aleafia Health Enters into Supply Agreement with Robes Cannabis Inc

Aleafia Health Launches High Potency CBD 50 Cannabis Oil

Aleafia Health Inc. Launches Kin Slips® Rapid Onset Cannabis-Infused Sublingual Strips

Third quarter 2020 earnings released: CA$0.066 loss per share

Aleafia Health Inc. Announces Successful Outdoor Harvest Accelerates Product Portfolio Expansion

Aleafia Health Inc. to Report Q3, 2020 Results on Nov 11, 2020

Aleafia Health Inc. Launches Cannabis 2.0 Portfolio with 510 Vape Cartridges Featuring Unique Formulations

New 90-day low: €0.25

First half earnings released

Aleafia Health Inc. to Report Q2, 2020 Results on Aug 12, 2020

Analyse CEO-vergoeding

CEO

Tenure